These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1682023)

  • 21. Mucosal gatekeepers: selecting HIV viruses for early infection.
    Bomsel M; David V
    Nat Med; 2002 Feb; 8(2):114-6. PubMed ID: 11821891
    [No Abstract]   [Full Text] [Related]  

  • 22. A strategy for prophylactic vaccination against HIV.
    Salk J; Bretscher PA; Salk PL; Clerici M; Shearer GM
    Science; 1993 May; 260(5112):1270-2. PubMed ID: 8098553
    [No Abstract]   [Full Text] [Related]  

  • 23. Toward an understanding of the correlates of protective immunity to HIV infection.
    Haynes BF; Pantaleo G; Fauci AS
    Science; 1996 Jan; 271(5247):324-8. PubMed ID: 8553066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A multicenter study of correlation between peripheral lymphocyte counts and CD(+)4T cell counts in HIV/AIDS patients].
    Xie J; Qiu Z; Han Y; Li Y; Song X; Li T
    Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):118-21. PubMed ID: 25907841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological and serological markers predictive of progression to AIDS in a cohort of HIV-infected drug users.
    Fernández-Cruz E; Desco M; Garcia Montes M; Longo N; Gonzalez B; Zabay JM
    AIDS; 1990 Oct; 4(10):987-94. PubMed ID: 1979743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.
    Zinkernagel RM; Hengartner H
    Immunol Today; 1994 Jun; 15(6):262-8. PubMed ID: 7915115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative changes in T helper inducer (CD4+ CD45RA-), T suppressor inducer (CD4+ CD45RA+), T suppressor (CD8+ CD11b+), and T cytotoxic (CD8+ CD11b-) subsets in human immunodeficiency virus infection.
    Reddy MM; Grieco MH
    J Clin Lab Anal; 1991; 5(2):96-100. PubMed ID: 2023064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years.
    Keet IP; Janssen M; Veugelers PJ; Miedema F; Klein MR; Goudsmit J; Coutinho RA; de Wolf F
    J Infect Dis; 1997 Sep; 176(3):665-71. PubMed ID: 9291313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hiv and AIDS infection. A. History, definition and classification].
    Cran S
    Acta Urol Belg; 1993; 61(1-2):353-61. PubMed ID: 8517255
    [No Abstract]   [Full Text] [Related]  

  • 30. AIDS therapy. Failure isn't what it used to be...but neither is success.
    Cohen J
    Science; 1998 Feb; 279(5354):1133-4. PubMed ID: 9508685
    [No Abstract]   [Full Text] [Related]  

  • 31. AIDS pathogenesis: a finite immune response to blame?
    Miedema F; Klein MR
    Science; 1996 Apr; 272(5261):505-6. PubMed ID: 8614796
    [No Abstract]   [Full Text] [Related]  

  • 32. AIDS: immunologic abnormalities following human immunodeficiency virus infection.
    Batra P
    J Thorac Imaging; 1991 Sep; 6(4):1-5. PubMed ID: 1942190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV results in the frame. Other approaches.
    Bukrinsky M; Manogue K; Cerami A
    Nature; 1995 May; 375(6528):195-6; author reply 198. PubMed ID: 7746316
    [No Abstract]   [Full Text] [Related]  

  • 34. [Simplified CD4+ T-lymphocyte count in patients with HIV/AIDS in Mexico].
    Guarner J; Sánchez-Mejorada-Fernández G; del Río-Chiriboga C; Mohar A
    Salud Publica Mex; 1996; 38(3):207-11. PubMed ID: 8757546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AIDS patients can tolerate a substantial loss of CD4 cells.
    Oncology (Williston Park); 1992 Jan; 6(1):97-8. PubMed ID: 1346966
    [No Abstract]   [Full Text] [Related]  

  • 36. Serologic confirmation of HIV infection.
    Chronister CL
    Optom Vis Sci; 1995 May; 72(5):299-301. PubMed ID: 7667004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group.
    Schneider T; Jahn HU; Schmidt W; Riecken EO; Zeitz M; Ullrich R
    Gut; 1995 Oct; 37(4):524-9. PubMed ID: 7489940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune restoration think tank 5.
    Bowers M
    BETA; 1995 Dec; ():13, 53. PubMed ID: 11363004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
    Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
    N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine.
    Choi S; Lagakos SW; Schooley RT; Volberding PA
    Ann Intern Med; 1993 May; 118(9):674-80. PubMed ID: 8096373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.